$229 Million is the total value of TRV GP III, LLC's 6 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 14.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PLRX | Sell | PLIANT THERAPEUTICS, INC. | $80,200,000 | +71.5% | 3,839,160 | -34.3% | 35.02% | +83.1% |
RVMD | Sell | REVOLUTION MEDICINES, INC. | $71,073,000 | -28.6% | 3,604,130 | -29.4% | 31.03% | -23.7% |
VYGR | Sell | VOYAGER THERAPEUTICS, INC. | $32,139,000 | -14.9% | 5,428,933 | -15.1% | 14.03% | -9.2% |
FULC | FULCRUM THERAPEUTICS, INC. | $32,054,000 | +65.1% | 3,962,202 | 0.0% | 14.00% | +76.2% | |
DBTX | DECIBEL THERAPEUTICS, INC. | $10,863,000 | -17.8% | 3,139,685 | 0.0% | 4.74% | -12.3% | |
JNCE | JOUNCE THERAPEUTICS, INC. | $2,688,000 | -22.8% | 1,148,780 | 0.0% | 1.17% | -17.6% | |
NRIX | Exit | NURIX THERAPEUTICS, INC. | $0 | – | -1,922,549 | -100.0% | -9.96% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Mark Levin #1
- Kevin P. Starr #2
- Robert I. Tepper #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. | 22 | Q1 2023 | 74.0% |
JOUNCE THERAPEUTICS, INC. | 20 | Q3 2022 | 24.5% |
PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 100.0% |
FULCRUM THERAPEUTICS, INC. | 14 | Q4 2022 | 43.8% |
REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 53.8% |
DECIBEL THERAPEUTICS, INC. | 10 | Q2 2023 | 66.3% |
NEON THERAPEUTICS, INC. | 8 | Q1 2020 | 41.1% |
NURIX THERAPEUTICS, INC. | 8 | Q2 2022 | 17.7% |
RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 37.7% |
MYOKARDIA, INC. | 2 | Q1 2018 | 22.1% |
View TRV GP III, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
4 | 2023-02-06 |
4 | 2023-02-01 |
4 | 2023-01-31 |
4 | 2023-01-26 |
4 | 2023-01-24 |
View TRV GP III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.